Author(s): Neeta Thakur


DOI: 10.52711/2349-2996.2021.00136   

Address: Neeta Thakur
M.Sc. (Obstetrics and Gynecological Nursing), Ph. D Scholar Clinical Instructor, Army College of Nursing, Jalandhar, Cantt.
*Corresponding Author

Published In:   Volume - 11,      Issue - 4,     Year - 2021

Antiphospholipid syndrome (APLS) is an acquired is auto immune disorder that is defined by the presence of antibodies known as antiphospholipid antibodies in addition to clinical thrombosis and/ or poor obstetric outcome. Although the incidence remains unknown, 10% to 15% of women with a history of recurrent pregnancy loss will meet the criteria for APLS. In these Patients, the annual incidence of deep vein thrombosis and stroke is 1.46% and 0.32% respectively. Compared with the annual incidence in the general population of 0.1% for deep vein thrombosis and 0.1% for stroke.1

Cite this article:
Neeta Thakur. Antiphospholipid Syndrome – Early Pregnancy Loss. Asian Journal of Nursing Education and Research. 2021; 11(4):585-0. doi: 10.52711/2349-2996.2021.00136

Neeta Thakur. Antiphospholipid Syndrome – Early Pregnancy Loss. Asian Journal of Nursing Education and Research. 2021; 11(4):585-0. doi: 10.52711/2349-2996.2021.00136   Available on:

1.    Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002 Mar 07;346(10): 752-63.
2.    Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost. 2002 Apr; 87(4): 599-605. [PubMed]
3.    Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013; 2013: 675-80.
4.    Olech E, Merrill JT. The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis. Curr Rheumatol Rep. 2006 Apr; 8(2): 100-8.
5.    Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996 Jul; 66(1): 24-9.
6.    Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Moffatt K, Johnston M, Stevens P, Hirsh J. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995 Nov 15; 86(10): 3685-91.
7.    Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992 Dec 15;117(12): 997-1002.
8.    Pengo V, Biasiolo A, Pegoraro C, Cucchini U, Noventa F, Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost. 2005 Jun;93(6): 1147-52.
9.    Les I, Ruiz-Irastorza G, Khamashta MA. Intensity and duration of anticoagulation therapy in antiphospholipid syndrome. Semin Thromb Hemost. 2012 Jun;38(4): 339-47.
10.    Espínola-Zavaleta N, Vargas-Barrón J, Colmenares-Galvis T, Cruz- Cruz F, Romero-Cárdenas A, Keirns C, Amigo  MC. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J. 1999 May;137(5): 973-8.
11.    Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M., Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 Apr;46(4): 1019-27.
12.    Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, Ramos-Casals M, Ingelmo M, Piette JC, Shoenfeld Y, Asherson RA., Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2005 Aug;64(8): 1205-9.
13.    Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa MC, Piette JC, Khamashta MA, Shoenfeld Y., Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12(7): 530-4.
14.    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295-306.
15.    Wahl DG, Bounameaux H, de Moerloose P, Sarasin FP. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med. 2000 Jul 10;160(13): 2042-8.
16.    Garcia DA, Khamashta MA, Crowther MA. How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood. 2007 Nov 01; 110(9): 3122-7.
17.    Erkan D, Yazici Y, Sobel R, Lockshin MD. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol. 2000 Dec;27(12):2817-21.

Recomonded Articles:

Author(s): P. L. Murugalakshmi

DOI: 10.5958/2349-2996.2018.00058.7         Access: Open Access Read More

Author(s): Gehan. H.Soliman, Seham Mohamed Abd Elalem, Samah Mohamed Elhomosy

DOI: 10.5958/2349-2996.2017.00065.9         Access: Open Access Read More

Author(s): Arun Kumar Jindal, Rimpy, Kiranjeet Kaur, Harpreet Kaur, Rahul

DOI: 10.5958/2349-2996.2017.00046.5         Access: Open Access Read More

Author(s): Sandhya D. Almeida, Leena D’Souza, Sequeira Maria Deepthi

DOI: 10.5958/2349-2996.2017.00005.2         Access: Open Access Read More

Author(s): Dharitri Swain

DOI:         Access: Open Access Read More

Author(s): Mrs. Priyanka A Masih

DOI: 10.5958/2349-2996.2020.00036.1         Access: Open Access Read More

Asian Journal of Nursing Education and Research (AJNER) is an international, peer-reviewed journal devoted to nursing sciences....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2349-2996 

Popular Articles

Recent Articles